Evidence map›Paper›PMID 34056327›Full record

ArticleACS omega2021

Substrate-Controlled Cu(OAc)

Jiuzhong Huang, Xiaoning Li, Huiling Wen, Lu Ouyang, Nianhua Luo, Jianhua Liao, Renshi Luo

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Catalytic,Journal of the American Chemical Society · 2023
    Article
  4. Article
  5. Copper-Catalyzed Diboron-MediatedMolecules (Basel, Switzerland) · 2022
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jiuzhong HuangSchool of Pharmacy, Gannan Medical University, Ganzhou 341000, P. R. China.ORCID 0000-0002-6474-7707
Xiaoning LiKey Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Ganzhou 341000, P. R. China.
Huiling WenSchool of Pharmacy, Gannan Medical University, Ganzhou 341000, P. R. China.
Lu OuyangSchool of Pharmacy, Gannan Medical University, Ganzhou 341000, P. R. China.
Nianhua LuoSchool of Pharmacy, Gannan Medical University, Ganzhou 341000, P. R. China.
Jianhua LiaoSchool of Pharmacy, Gannan Medical University, Ganzhou 341000, P. R. China.ORCID 0000-0001-8564-5841
Renshi LuoSchool of Pharmacy, Gannan Medical University, Ganzhou 341000, P. R. China.ORCID 0000-0001-8966-0387
Gannan Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A substrate-controlled stereoselective semi-reduction of alkynes with MeOH as the hydrogen source has been developed, and readily available Cu(OAc)

Identifiers

PMID34056327
PMCPMC8154033
OpenAlexW3159918817

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.